DH

Definitive Healthcare

Stock NASDAQ – Stock Market Prices, News & Analysis

Definitive Healthcare Corp fournit des données, des analyses et des insights dans le secteur des soins de santé pour aider à la prise de décision.

$ 1.15
3.38 %

Definitive Healthcare

$ 1.15
3.38 %
DH

Definitive Healthcare Corp fournit des données, des analyses et des insights dans le secteur des soins de santé pour aider à la prise de décision.

Price history of Definitive Healthcare
Price history of Definitive Healthcare

Performance & Momentum

6 Months 72.58 %
1 Year 60.04 %
3 Years 89.95 %
5 Years 97.68 %
Momentum
79

Strategic Analysis

Definitive Healthcare • 2026

Definitive Healthcare Corp positions itself as a specialized provider of data and analytics dedicated to the healthcare sector in the United States, aiming to facilitate strategic decision-making. Its model is based on the valuation of clinical and commercial information, a critical niche in an increasingly data-driven environment.

Strengths
  • Targeted sector expertise in healthcare providing accurate and relevant data
  • Strategic insights essential for industry players
  • Economic model based on recurring subscriptions fostering visibility on revenue
Weaknesses
  • Sustained poor stock performance over multiple time horizons, reflecting operational or market challenges
  • Lack of positive momentum or recent catalyst to reverse the negative trend
Momentum

The current neutral momentum reflects a phase of marked caution characterized by a prolonged decline in share prices, with no tangible signs of immediate recovery. The absence of favorable news or visible catalysts limits attractiveness for dynamic short-term investment.

Analysis performed 2 weeks ago

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone